Frontiers in Oncology (Aug 2019)
Active-Scanned Protons and Carbon Ions in Cancer Treatment of Patients With Cardiac Implantable Electronic Devices: Experience of a Single Institution
- Katharina Seidensaal,
- Katharina Seidensaal,
- Katharina Seidensaal,
- Katharina Seidensaal,
- Semi Ben Harrabi,
- Semi Ben Harrabi,
- Semi Ben Harrabi,
- Semi Ben Harrabi,
- Semi Ben Harrabi,
- Eberhard Scholz,
- Eberhard Scholz,
- Eberhard Scholz,
- Malte Ellerbrock,
- Malte Ellerbrock,
- Malte Ellerbrock,
- Thomas Haberer,
- Thomas Haberer,
- Thomas Haberer,
- Fabian Weykamp,
- Fabian Weykamp,
- Fabian Weykamp,
- Fabian Weykamp,
- Matthias Mattke,
- Matthias Mattke,
- Matthias Mattke,
- Matthias Mattke,
- Stefan E. Welte,
- Stefan E. Welte,
- Stefan E. Welte,
- Klaus Herfarth,
- Klaus Herfarth,
- Klaus Herfarth,
- Klaus Herfarth,
- Klaus Herfarth,
- Jürgen Debus,
- Jürgen Debus,
- Jürgen Debus,
- Jürgen Debus,
- Jürgen Debus,
- Jürgen Debus,
- Matthias Uhl,
- Matthias Uhl,
- Matthias Uhl,
- Matthias Uhl
Affiliations
- Katharina Seidensaal
- Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
- Katharina Seidensaal
- Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany
- Katharina Seidensaal
- National Center for Tumor Diseases (NCT), Heidelberg, Germany
- Katharina Seidensaal
- Department of Radiation Oncology, Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg University Hospital, Heidelberg, Germany
- Semi Ben Harrabi
- Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
- Semi Ben Harrabi
- Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany
- Semi Ben Harrabi
- National Center for Tumor Diseases (NCT), Heidelberg, Germany
- Semi Ben Harrabi
- Department of Radiation Oncology, Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg University Hospital, Heidelberg, Germany
- Semi Ben Harrabi
- Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
- Eberhard Scholz
- Heidelberg Center for Heart Rhythm Disorders (HCR), Heidelberg, Germany
- Eberhard Scholz
- Department of Cardiology, Heidelberg University Hospital, Heidelberg, Germany
- Eberhard Scholz
- DZHK (German Centre for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Heidelberg, Germany
- Malte Ellerbrock
- Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
- Malte Ellerbrock
- Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany
- Malte Ellerbrock
- Department of Radiation Oncology, Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg University Hospital, Heidelberg, Germany
- Thomas Haberer
- Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
- Thomas Haberer
- Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany
- Thomas Haberer
- Department of Radiation Oncology, Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg University Hospital, Heidelberg, Germany
- Fabian Weykamp
- Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
- Fabian Weykamp
- Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany
- Fabian Weykamp
- National Center for Tumor Diseases (NCT), Heidelberg, Germany
- Fabian Weykamp
- Department of Radiation Oncology, Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg University Hospital, Heidelberg, Germany
- Matthias Mattke
- Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
- Matthias Mattke
- Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany
- Matthias Mattke
- National Center for Tumor Diseases (NCT), Heidelberg, Germany
- Matthias Mattke
- Department of Radiation Oncology, Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg University Hospital, Heidelberg, Germany
- Stefan E. Welte
- Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
- Stefan E. Welte
- Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany
- Stefan E. Welte
- National Center for Tumor Diseases (NCT), Heidelberg, Germany
- Klaus Herfarth
- Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
- Klaus Herfarth
- Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany
- Klaus Herfarth
- National Center for Tumor Diseases (NCT), Heidelberg, Germany
- Klaus Herfarth
- Department of Radiation Oncology, Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg University Hospital, Heidelberg, Germany
- Klaus Herfarth
- Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
- Jürgen Debus
- Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
- Jürgen Debus
- Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany
- Jürgen Debus
- National Center for Tumor Diseases (NCT), Heidelberg, Germany
- Jürgen Debus
- Department of Radiation Oncology, Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg University Hospital, Heidelberg, Germany
- Jürgen Debus
- Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
- Jürgen Debus
- German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany
- Matthias Uhl
- Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
- Matthias Uhl
- Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany
- Matthias Uhl
- National Center for Tumor Diseases (NCT), Heidelberg, Germany
- Matthias Uhl
- Department of Radiation Oncology, Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg University Hospital, Heidelberg, Germany
- DOI
- https://doi.org/10.3389/fonc.2019.00798
- Journal volume & issue
-
Vol. 9
Abstract
Background: Ionizing radiation was shown to be able to influence the function of cardiac implantable electronic devices (CIED's) leading to malfunctions with potentially severe consequences. Those effects presumably correlate with beam energy and neutron production. Thus, particle facilities are commonly cautious to treat patients with CIED's with particles, but substantial evidence is lacking.Methods and Materials: In total 31 patients were investigated, who have been treated at the Heidelberg Ion-Beam Therapy Center (HIT) from September 2012 to February 2019 with protons and carbon ions in active-scanning technique. All CIED's were checked after every single irradiation by the department of cardiology. The minimum distance between the CIED and the planning target volume (PTV), the 10% isodose and the single beam in Beam's Eye View (BEV) was analyzed for 12 patients.Results: In total, 31 patients received 32 courses of radiotherapy (RT). Twenty-two received treatment with carbon ion beam and ten with proton beam. The cumulative number of fractions was 582, the cumulative number of documented controls after RT was 504 (87%). Three patients had an implantable cardioverter-defibrillator (ICD) and 28 patients had a pacemaker at the time of treatment. Seven patients had a heart rate of ≤30/min. The majority of patients (69%) were treated for tumors of the head and neck. The median minimum distance between CIED and PTV, 10% isodose and the single beam on BEV was 13.4, 11.6, and 8.3 cm, respectively. There were no registered events associated with the treatment in this evaluation.Conclusion: Treatment of CIED-patients with protons and carbon ions applied with active raster scanning technique was safe without any incidents in our single center experience. Monitoring after almost every fraction provided systematic and extensive data. Further investigations are necessary in order to form reliable guidelines, which should consider different modes of beam application, as active scanning supposedly provides a greater level of safety from malfunctions for patients with CIED undergoing particle irradiation.
Keywords
- particle therapy
- beam scanning
- cardiac implantable electronic device
- CIED malfunction
- carbon ion radiotherapy
- proton radiotherapy